rivastigmine
Selected indexed studies
- Effects of rivastigmine on gait in patients with neurodegenerative disorders: A systematic review and meta-analysis. (PLoS One, 2024) [PMID:39666629]
- Rivastigmine for treatment-refractory posttraumatic stress disorder: a systematic review. (East Asian Arch Psychiatry, 2024) [PMID:38955788]
- Efficacy and safety of donepezil, galantamine, and rivastigmine for the treatment of Alzheimer's disease: a systematic review and meta-analysis. (Clin Interv Aging, 2008) [PMID:18686744]
_Worker-drafted node — pending editorial review._
Connections
rivastigmine is a side effect of
Sources
- Efficacy and safety of donepezil, galantamine, and rivastigmine for the treatment of Alzheimer's disease: a systematic review and meta-analysis. (2008) pubmed
- Effects of rivastigmine on gait in patients with neurodegenerative disorders: A systematic review and meta-analysis. (2024) pubmed
- Rivastigmine for treatment-refractory posttraumatic stress disorder: a systematic review. (2024) pubmed
- Rivastigmine for Alzheimer's disease. (2005) pubmed
- Update on rivastigmine. (2003) pubmed
- Rivastigmine for Alzheimer's disease. (2000) pubmed
- Rivastigmine for Alzheimer's disease. (2000) pubmed
- Rivastigmine for subcortical vascular dementia. (2005) pubmed
- Rivastigmine: in Parkinson's disease dementia. (2006) pubmed
- Rivastigmine for the management of anticholinergic delirium. (2024) pubmed